2024-04755. Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Organic Consultants LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 6, 2024. Such persons may also file a written request for a hearing on the application on or before May 6, 2024.

    ADDRESSES:

    The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on January 24, 2024, Organic Consultants LLC DBA Cascade Chemistry, 90 North Polk Street, Suite 200, Eugene, Oregon 97402–4109, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Amphetamine1100II
    Methylphenidate1724II
    Codeine9050II
    Oxycodone9143II
    Hydromorphone9150II
    Hydrocodone9193II
    Meperidine9230II
    Meperidine intermediate-A9232II
    Start Printed Page 16033
    Meperidine intermediate-B9233II
    Meperidine intermediate-C9234II
    Methadone9250II
    Methadone intermediate9254II
    Morphine9300II
    Thebaine9330II
    Oxymorphone9652II
    Noroxymorphone9668II
    Fentanyl9801II

    The company plans to bulk manufacture small quantities of the listed controlled substances for internal use or for sale as analytical reference standard materials to its customers. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Marsha L. Ikner,

    Acting Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2024–04755 Filed 3–5–24; 8:45 am]

    BILLING CODE P

Document Information

Published:
03/06/2024
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2024-04755
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 6, 2024. Such persons may also file a written request for a hearing on the application on or before May 6, 2024.
Pages:
16032-16033 (2 pages)
Docket Numbers:
Docket No. DEA-1331
PDF File:
2024-04755.pdf